Open AccessAcute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo‐Controlled Trial
Author(s) -
Anne Zanchi,
Michel Burnier,
Müller Me,
Arlène GhajarzadehWurzner,
Marc Maillard,
Nicolas Loncle,
Bastien Milani,
Nathalie Dufour,
Olivier Bonny,
Menno Pruijm
Publication year - 2020
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.119.016173
Subject(s) - medicine , empagliflozin , blood pressure , placebo , randomized controlled trial , cardiology , anesthesia , diabetes mellitus , type 2 diabetes , endocrinology , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom